Literature DB >> 28033507

Regulatory region genetic variation is associated with FYN expression in Alzheimer's disease.

Jeffrey A Zahratka1, Yvonne Shao2, McKenzie Shaw2, Kaitlin Todd2, Shane V Formica2, Maria Khrestian2, Thomas Montine3, James B Leverenz4, Lynn M Bekris2.   

Abstract

Neurofibrillary tangles (NFTs), composed of hyperphosphorylated tau, are a key pathologic feature of Alzheimer's disease (AD). Tau phosphorylation is under the control of multiple kinases and phosphatases, including Fyn. Previously, our group found an association between 2 regulatory single nucleotide polymorphisms in the FYN gene with increased tau levels in the cerebrospinal fluid. In this study, we hypothesized that Fyn expression in the brain is influenced by AD status and genetic content. We found that Fyn protein, but not messenger RNA, levels were increased in AD patients compared to cognitively normal controls and are associated with regulatory region single nucleotide polymorphisms. In addition, the expression of the FYN 3'UTR can decrease expression in multiple cell lines, suggesting this regulatory region plays an important role in FYN expression. Taken together, these data suggest that FYN expression is regulated according to AD status and regulatory region haplotype, and genetic variants may be instrumental in the development of neurofibrillary tangles in AD and other tauopathies.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cerebellum; Fyn; Hippocampus; Reporter assay; SNP

Mesh:

Substances:

Year:  2016        PMID: 28033507      PMCID: PMC5358011          DOI: 10.1016/j.neurobiolaging.2016.11.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  55 in total

1.  The protein phosphatase PP2A/Bα binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies.

Authors:  Jean-Marie Sontag; Viyada Nunbhakdi-Craig; Charles L White; Shelley Halpain; Estelle Sontag
Journal:  J Biol Chem       Date:  2012-03-08       Impact factor: 5.157

2.  Collapsing SNP genotypes in case-control genome-wide association studies increases the type I error rate and power.

Authors:  Abigail G Matthews; Chad Haynes; Chang Liu; Jurg Ott
Journal:  Stat Appl Genet Mol Biol       Date:  2008-07-25

3.  Microtubule-associated proteins regulate microtubule function as the track for intracellular membrane organelle transports.

Authors:  R Sato-Harada; S Okabe; T Umeyama; Y Kanai; N Hirokawa
Journal:  Cell Struct Funct       Date:  1996-10       Impact factor: 2.212

4.  Identification of an alternatively spliced isoform of the fyn tyrosine kinase.

Authors:  Jeffrey F Goldsmith; Craig G Hall; T Prescott Atkinson
Journal:  Biochem Biophys Res Commun       Date:  2002-11-08       Impact factor: 3.575

5.  Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines.

Authors:  Di Xia; Chuanzhou Li; Jürgen Götz
Journal:  Biochim Biophys Acta       Date:  2015-01-03

6.  Pathological stress granules in Alzheimer's disease.

Authors:  Peter E A Ash; Tara E Vanderweyde; Katherine L Youmans; Daniel J Apicco; Benjamin Wolozin
Journal:  Brain Res       Date:  2014-08-07       Impact factor: 3.252

7.  Unique catalytic properties dictate the enhanced function of p59fynT, the hemopoietic cell-specific isoform of the Fyn tyrosine protein kinase, in T cells.

Authors:  D Davidson; J Viallet; A Veillette
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

8.  Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.

Authors:  Valeriy Duka; Jae-Hoon Lee; Joel Credle; Jonathan Wills; Adam Oaks; Ciaran Smolinsky; Ketul Shah; Deborah C Mash; Eliezer Masliah; Anita Sidhu
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

Review 9.  Fyn kinase inhibition as a novel therapy for Alzheimer's disease.

Authors:  Haakon B Nygaard; Christopher H van Dyck; Stephen M Strittmatter
Journal:  Alzheimers Res Ther       Date:  2014-02-05       Impact factor: 6.982

Review 10.  Tau aggregation and its interplay with amyloid-β.

Authors:  Rebecca M Nisbet; Juan-Carlos Polanco; Lars M Ittner; Jürgen Götz
Journal:  Acta Neuropathol       Date:  2014-12-10       Impact factor: 17.088

View more
  2 in total

Review 1.  Targeting Fyn Kinase in Alzheimer's Disease.

Authors:  Haakon B Nygaard
Journal:  Biol Psychiatry       Date:  2017-06-13       Impact factor: 13.382

2.  Loss of miR-369 Promotes Tau Phosphorylation by Targeting the Fyn and Serine/Threonine-Protein Kinase 2 Signaling Pathways in Alzheimer's Disease Mice.

Authors:  Xiaoguang Yao; Xiaohui Xian; Mingxing Fang; Shujuan Fan; Wenbin Li
Journal:  Front Aging Neurosci       Date:  2020-01-31       Impact factor: 5.750

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.